Rabia KhanCEO at Serna BioSpeaker
Profile
Rabia Khan, PhD, MBA is the founder and CEO of Serna Bio, a biotechbuilding the world's first map of the druggable transcriptome to addressnovel inaccessible biology.Before founding Serna Bio, Dr. Khan was Managing Director of DiscoverySciences at Sensyne Health Plc (now: Arcturis) where she established thescientific strategy, built the data science and discovery teams and led thepharma partnerships with Bayer, BMS, Roche and Alexion and others. She has also held seniorroles at BenevolentAI and Meta (acquired by Chan Zuckerberg BioHub).Born and raised in Pakistan, Dr. Khan is passionate about supporting diversity in technologyand initiatives focused on improving access to care and availability of medicine.
Agenda Sessions
Mapping the Functional Transcriptome
, 4:30pmView SessionChair Opening Address: Next-Generation RNA Innovation
, 11:10amView Session